Clinical trial
Therapy for Children With Neuroblastoma
NCT00135135 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00135135 |
|---|---|
| Title | Therapy for Children With Neuroblastoma |
| Official title | Neuroblastoma Protocol 2005: Therapy for Children With Advanced Stage High-Risk Neuroblastoma |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | AstraZeneca Industry National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Drug, Procedure |
| Interventions | Gefitinib, Irinotecan, Cycophosphamide, Doxorubicin, Etoposide, Cisplatin, Topotecan, Carboplatin, Melphalan, 13-cis retinoic acid and 3 more |
| Enrollment | 23 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Aug 25, 2005 |
| Last update posted | Jun 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: